Return to homepagePandemic Pact

GENERATING AN EFFECTIVE T-CELL BASED INFLUENZA VACCINE

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA201634

Grant search

Key facts

  • Disease

    Unspecified

  • Start & end year

    2022
    2026

  • Known Financial Commitments (USD)

    $1,008,844.89

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Research Location

    Australia

  • Lead Research Institution

    University of Melbourne

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine design and administration

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Influenza is a highly contagious, rapidly spreading respiratory pathogen that causes profound morbidity and mortality. Current influenza vaccines are suboptimal, they need to be updated and administered annually, and provide no protection in the event of a pandemic influenza outbreak. This research program will see the development of a novel universal 'one-shot’ influenza vaccine that provides long term protection against both seasonal and newly emerging pandemic influenza strains.